BeStock  
Stocks › Biotechnology › NVCT

Nuvectis Pharma NVCT

US equityMarket cap rank #3552Biotechnology
$20.29 +$0.26 (+1.30%)
Market closed · Oct 8, 5:40 am ET · Last extended-hours $20.29 0.00%
Open$19.67
Prev close$20.03
Day range$19.67 – $20.72
Volume121.1K
Market cap$662.35M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-15.4x
CheapRich

Near the bottom of its 5-year range · 4th percentile, 5-year average -7.2x

Price / book73.0x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 13.5x

#5263 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-21x-10x1x12xFeb '22May '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$20.76
Price vs. fair value-2.3%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 72.99 – 13.54 97% (pricier than usual) #5263 of 5317 (1 = cheapest)
PE -15.37 -21.86 -7.24 4% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$20.76
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on NVCT.

Leave a comment

Scroll to Top